Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis

Clinical and Experimental Immunology

Volumn 107, Issue 2, 1997, Pages 248-253

  Santos, L L ^a   Morand, E F ^a   Hutchinson, P ^a   Boyce, N W ^a   Holdsworth, S R ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

adjuvant arthritis; CD4+ cell; complement; monoclonal antibody; neutrophil

Indexed keywords

CD4 ANTIGEN; COMPLEMENT; GRANULOCYTE ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031023131     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.263-ce1154.x     Document Type: Article

References (44)

1. Zvaifler NJ. Further speculation on the pathogenesis, of joint inflammation in rhematoid arthritis. Arthritis Rheum 1970; 13:895-901.
2. Santos L, Tipping PG. Attenuation of adjuvant arthritis in rats by treatment with oxygen radical scavengers. Immunol Cell Biol 1994; 72:406-14.
3. Quayle JA, Adams S, Bucknall RC, Edwards SW. Cytokine expression by inflammatory neutrophils. FEMS Immunol Med Microbiol 1994; 8:233-9.
4. Kitsis E, Weissmann G. The role of the neutrophil in rheumatoid arthritis. Clin Orthop 1991; 265:63-72.
5. Grisham MB, Yamada T. Neutrophils, nitrogen oxides, and inflammatory bowel disease. Ann NY Acad Sci 1992; 664:103-15.
6. McCarthy DA, Bernhagen J, Taylor MJ, Hamblin AS, James I, Thompson PW, Perry JD. Morphological evidence that activated polymorphs circulate in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis 1992; 51:13-18.
7. Nurcombe HL, Bucknall RC, Edwards SW. Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo. Ann Rheum Dis 1991; 50:147-153.
8. Hollingsworth JW, Siegel ER, Creasey WA. Granulocyte survival in synovial exudate of patients with rheumatoid arthritis and other inflammatory joint diseases. Yale J Biol Med 1967; 39:289-96.
9. Robinson JJ, Watson F, Phelan M, Bucknall RC, Edwards SW. Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis. Ann Rheum Dis 1993; 52:347-53.
10. Watson F, Robinson JJ, Phelan M, Bucknall RC, Edwards SW. Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis. Ann Rheum Dis 1993; 52:354-9.
11. Leirisalo-Repo M. The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol 1994; 75:1-3.
12. Sekiya S, Yamashita T, Sendo F. Suppression of late phase enhanced vascular permeability in rats by selective depletion of neutrophils with a monoclonal antibody. J Leuk Biol 1990; 48:258-65.
13. +) T lymphocyte recruitment into subcutaneous tissues of rats by selective depletion of in vivo neutrophils with a monoclonal antibody. J Immunol 1991; 147:2196-201.
14. Kudo C, Yamashita T, Araki A Terashita M, Watanabe T, Atsumi M, Tamura M, Sendo F. Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP. Inhibition by RP3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats. J Immunol 1993; 150:3728-38.
15. Kudo C, Yamashita T, Terashita M, Sendo F. Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP3. II. Inhibition by RP3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats. J Immunol 1993; 150:3739-46.
16. Tamura M, Sekiya S, Terashita M, Sendo F. Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP3. III. Enhancement by RP3 treatment of the antisheep red blood cell plaque-forming cell response in rats. J Immunol 1994; 153:1301-8.
17. Gotoh S, Itoh M, Fuji Y, Arai S, Sendo F. Enhancement of the expression of a rat neutrophil-specific cell surface antigen by activation with phorbol myristate acetate and concanavalin A. J Immunol 1986; 137:643-50.
18. Sekiya S, Gotoh S, Yamashita T, Watanabe T, Saitoh S, Sendo F. Selective depletion of rat neutrophils by in vivo administration of a monoclonal antibody. J Leuk Biol 1989; 46:96-102.
19. Klareskog L, Holmdahl R, Larsson E, Wigzell H. Role of T-lymphocytes in collagen II-induced arthritis in rats. Clin Exp Immunol 1983; 51:117-25.
20. Taurog JD, Sandberg GP, Mahowald ML. The cellular basis of adjuvant arthritis II. Cell Immunol 1983; 80:198-204.
21. Van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR. Arthritis induced by a T-lymphocyte clone that responds to mycobacterial tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 1985; 82:5117-20.
22. Yoshino S, Cleland LG. Depletion of alpha/beta T cells by a monoclonal antibody agaisnt the alpha/beta T cell receptor suppresses established AA, but not established collagen-induced arthritis in rats. J Exp Med 1992; 175:907-15.
23. Billingham MEJ, Hicks C, Carney S. Monoclonal antibodies and arthritis. Agents Actions 1990; 29:77-87.
24. Currey HLF, Ziff M. Suppression of adjuvant disease in the rat by heterologous anti lymphocyte globulin. J Exp Med 1968; 127:186-203.
25. Cochrane CG, Muller-Eberhard HJ, Aikin BS. Depletion of plasma complement in vivo by a protein of cobra venom: its effects on various immunologic reactions. J Immunol 1970; 105:55-69.
26. Ulevitch RJ, Cochrane CG, Henson PM, Morrison DC, Doe WF. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med 1975; 142:1570-90.
27. Taurog JD, Sandberg GP, Mahowald ML. The cellular basis of AA. Cell Immunol 1983; 80:198-204.
28. Janossy G, Panayi G, Duke O, Bofill M, Poulter LW, Goldstein G. Rheumatoid arthritis: a disease of T lymphocyte/macrophage immunoregulation. Lancet 1981; 2:839-42.
29. Henderson B, Pettipher ER, Higgs GA. Mediators of rheumatoid arthritis. B Med Bull 1987; 43:415-28.
30. Henderson B, Pettipher ER. The synovial lining cell: biology and pathobiology. Semin Arthritis Rheum 1985; 15:1-32.
31. Tsicopoulos A, Hamid Q, Haczku A et al. Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol 1994; 94:764-72.
32. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1988; 320:365-76.
33. Stefanovic-Racic M, Stadler J, Evans GH. Nitric oxide and arthritis. Arthritis Rheum 1993; 36:1036-42.
34. Czuprynski CJ, Brown JF, Maroushek N, Wagner RD, Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 1994; 152:1836-46.
35. Naish PF, Thomson NM, Simpson IJ, Peters DK. The role of polymorphonuclear leukocytes in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol 1975; 22:102-11.
36. Sato T, Shinzawa H, Abe Y, Takabashi T, Arai S, Sendo F. Inhibition of Corynebacterium parvum-primed and lipopolysaccharide-induced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody. J Leuk Biol 1993; 53:144-50.
37. Brown KA. The polymorphonuclear cell in rheumatoid arthritis. Br J Rheumatol 1988; 27:150-5.
38. Merry P, Winyard PG, Morris CJ, Grootveld M, Blake DR. Oxygen free radical, inflammation and synovitis: the current status. Ann Rheum Dis 1989; 48:864-70.
39. Stevens CR, Williams RB, Farrell AJ, Blake DR. Hypoxia and inflammatory synovitis: observation and speculation. Ann Rheum Dis 1991; 50:124-32.
40. 2 system by synovial fluid isolated from patients with rheumatoid arthritis. Biochem J 1991; 250:81-85.
41. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM. Suppression of arthritis by an inhibitor of NO synthase. J Exp Med 1993; 178:749-54.
42. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of IFN-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158:670-89.
43. Fattal-German M, Le Roy Ladurie F, Cerrina J, Lecerf F, Berrih-Aknin S. Expression of ICAM-1 on human alveolar macrophages. Ann Pharm Fr 1995; 53:97-110.
44. Loetscher P, Dewald B, Baggiolini M, Seitz M. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine 1994; 6:162-70.